Search research articles
Contact Us
Filters
Showing results (811-820 of 839) with videos related to
Page
of 84
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2017
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer
Anna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.
The Lancet. Respiratory Medicine
|
July 26, 2024
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
Jin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, et al.
Vaccine
|
May 25, 2024
A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicity
Jin-Yuan Wu, Wei Zhang, Jing Pu, et al.
Virology Journal
|
August 6, 2024
Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China
Jian-Peng Hu, Jun-Ling Wang, Yun Li, et al.
Virology Journal
|
July 14, 2025
Trends in the molecular epidemiology of human papillomavirus in males from the plateau region of Southwest China: an 11-year retrospective analysis (2014-2024)
Jian-Peng Hu, Jun-Ling Wang, Yun Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial
Yang-Si Li, Qitao Yu, Qing Bu, et al.
JTO Clinical and Research Reports
|
January 3, 2022
Real-World Survival Outcomes Based on <i>EGFR</i> Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study
Xue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.
Eclinicalmedicine
|
October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated <i>EGFR</i>-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial
Cheng Xu, Si-Yang Wang, Man Nie, et al.
Page
of 84
Search research articles
Search
Showing results (811-820 of 839) with videos related to
Sort By:
Page
of 84
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2017
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer
Anna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.
The Lancet. Respiratory Medicine
|
July 26, 2024
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
Jin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, et al.
Vaccine
|
May 25, 2024
A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicity
Jin-Yuan Wu, Wei Zhang, Jing Pu, et al.
Virology Journal
|
August 6, 2024
Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China
Jian-Peng Hu, Jun-Ling Wang, Yun Li, et al.
Virology Journal
|
July 14, 2025
Trends in the molecular epidemiology of human papillomavirus in males from the plateau region of Southwest China: an 11-year retrospective analysis (2014-2024)
Jian-Peng Hu, Jun-Ling Wang, Yun Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial
Yang-Si Li, Qitao Yu, Qing Bu, et al.
JTO Clinical and Research Reports
|
January 3, 2022
Real-World Survival Outcomes Based on <i>EGFR</i> Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study
Xue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.
Eclinicalmedicine
|
October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated <i>EGFR</i>-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial
Cheng Xu, Si-Yang Wang, Man Nie, et al.
Page
of 84